SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-066475
Filing Date
2017-11-07
Accepted
2017-11-07 08:33:49
Documents
58
Period of Report
2017-11-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-26050_18k.htm 8-K 22295
2 EX-99.1 a17-26050_1ex99d1.htm EX-99.1 86598
3 GRAPHIC g260501mmi001.gif GRAPHIC 240123
4 GRAPHIC g260501mmi002.gif GRAPHIC 149895
5 GRAPHIC g260501mmi003.gif GRAPHIC 126883
6 GRAPHIC g260501mmi004.gif GRAPHIC 107075
7 GRAPHIC g260501mmi005.gif GRAPHIC 107749
8 GRAPHIC g260501mmi006.gif GRAPHIC 136086
9 GRAPHIC g260501mmi007.gif GRAPHIC 301845
10 GRAPHIC g260501mmi008.gif GRAPHIC 106545
11 GRAPHIC g260501mmi009.gif GRAPHIC 134704
12 GRAPHIC g260501mmi010.gif GRAPHIC 301902
13 GRAPHIC g260501mmi011.gif GRAPHIC 81490
14 GRAPHIC g260501mmi012.gif GRAPHIC 93904
15 GRAPHIC g260501mmi013.gif GRAPHIC 87050
16 GRAPHIC g260501mmi014.gif GRAPHIC 301481
17 GRAPHIC g260501mmi015.gif GRAPHIC 88544
18 GRAPHIC g260501mmi016.gif GRAPHIC 96389
19 GRAPHIC g260501mmi017.gif GRAPHIC 85956
20 GRAPHIC g260501mmi018.gif GRAPHIC 98218
21 GRAPHIC g260501mmi019.gif GRAPHIC 70648
22 GRAPHIC g260501mmi020.gif GRAPHIC 113254
23 GRAPHIC g260501mmi021.gif GRAPHIC 80742
24 GRAPHIC g260501mmi022.gif GRAPHIC 140138
25 GRAPHIC g260501mmi023.gif GRAPHIC 110199
26 GRAPHIC g260501mmi024.gif GRAPHIC 104493
27 GRAPHIC g260501mmi025.gif GRAPHIC 88620
28 GRAPHIC g260501mmi026.gif GRAPHIC 90801
29 GRAPHIC g260501mmi027.gif GRAPHIC 123337
30 GRAPHIC g260501mmi028.gif GRAPHIC 115607
31 GRAPHIC g260501mmi029.gif GRAPHIC 136656
32 GRAPHIC g260501mmi030.gif GRAPHIC 140677
33 GRAPHIC g260501mmi031.gif GRAPHIC 118074
34 GRAPHIC g260501mmi032.gif GRAPHIC 73564
35 GRAPHIC g260501mmi033.gif GRAPHIC 84290
36 GRAPHIC g260501mmi034.gif GRAPHIC 94892
37 GRAPHIC g260501mmi035.gif GRAPHIC 232101
38 GRAPHIC g260501mmi036.gif GRAPHIC 89797
39 GRAPHIC g260501mmi037.gif GRAPHIC 93063
40 GRAPHIC g260501mmi038.gif GRAPHIC 75480
41 GRAPHIC g260501mmi039.gif GRAPHIC 61469
42 GRAPHIC g260501mmi040.gif GRAPHIC 107683
43 GRAPHIC g260501mmi041.gif GRAPHIC 91615
44 GRAPHIC g260501mmi042.gif GRAPHIC 123945
45 GRAPHIC g260501mmi043.gif GRAPHIC 77884
46 GRAPHIC g260501mmi044.gif GRAPHIC 82667
47 GRAPHIC g260501mmi045.gif GRAPHIC 139536
48 GRAPHIC g260501mmi046.gif GRAPHIC 124053
49 GRAPHIC g260501mmi047.gif GRAPHIC 97014
50 GRAPHIC g260501mmi048.gif GRAPHIC 122813
51 GRAPHIC g260501mmi049.gif GRAPHIC 137513
52 GRAPHIC g260501mmi050.gif GRAPHIC 109996
53 GRAPHIC g260501mmi051.gif GRAPHIC 119267
54 GRAPHIC g260501mmi052.gif GRAPHIC 88127
55 GRAPHIC g260501mmi053.gif GRAPHIC 103867
56 GRAPHIC g260501mmi054.gif GRAPHIC 125448
57 GRAPHIC g260501mmi055.gif GRAPHIC 85448
58 GRAPHIC g260501mmi056.gif GRAPHIC 113142
  Complete submission text file 0001104659-17-066475.txt   9389536
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 171181211
SIC: 2834 Pharmaceutical Preparations